TH110374B - Pharmaceutical solution - Google Patents
Pharmaceutical solutionInfo
- Publication number
- TH110374B TH110374B TH801003215A TH0801003215A TH110374B TH 110374 B TH110374 B TH 110374B TH 801003215 A TH801003215 A TH 801003215A TH 0801003215 A TH0801003215 A TH 0801003215A TH 110374 B TH110374 B TH 110374B
- Authority
- TH
- Thailand
- Prior art keywords
- pharmaceutical solution
- thymidine
- pharmaceutical
- stabilizing
- additive
- Prior art date
Links
- 239000003186 pharmaceutical solution Substances 0.000 title abstract 2
- 239000000654 additive Substances 0.000 claims abstract 2
- 230000000996 additive Effects 0.000 claims abstract 2
- 239000000796 flavoring agent Substances 0.000 claims abstract 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 229940100688 Oral Solution Drugs 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000005711 Benzoic acid Substances 0.000 claims 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N Saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 239000007979 citrate buffer Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 235000008504 concentrate Nutrition 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- IQFYYKKMVGJFEH-CSMHCCOUSA-N Telbivudine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1O[C@@H](CO)[C@H](O)C1 IQFYYKKMVGJFEH-CSMHCCOUSA-N 0.000 abstract 2
- 230000000087 stabilizing Effects 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 1
- 230000003750 conditioning Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drugs Drugs 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 229960005311 telbivudine Drugs 0.000 abstract 1
Abstract
สารละลายทางเภสัชกรรมที่เหมาะสมสำหรับการดำเนินการให้โดยการรับประทาน ประกอบด้วย (สูตร)-L-ไธมิดีน/2'-ดีออกซี-L-ไธมิดีน (เทลไบวูดีน), ระบบตัวทำละลายที่เหมาะสมทาง เภสัชกรรม, หนึ่งหรือมากกว่าหนึ่งสารเสริม/สารปกปิดกลิ่นรส, ระบบการรักษาสภาพ, และ ระบบบัฟเฟอร์ที่เหมาะสมต่อการยอมให้เกิดเสถียรและรักษาสภาพยา Pharmaceutical solutions suitable for oral administration include (formulation) -L-thymidine / 2'-deoxy-L-thymidine. (Telbivudine), a pharmaceutical suitable solvent system, one or more additive / flavoring agents, a conditioning system, and a buffer system suitable for stabilizing and stabilizing drugs.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH110374A TH110374A (en) | 2011-09-15 |
| TH110374B true TH110374B (en) | 2011-09-15 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2545395T3 (en) | Association of ivermectin with brimonidine for the treatment or prevention of rosacea | |
| JP2010529999A5 (en) | ||
| WO2005115406A3 (en) | 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents | |
| ATE493973T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN | |
| CY1118057T1 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| CA2414063A1 (en) | Highly concentrated stable meloxicam solutions | |
| JP2014530801A5 (en) | ||
| ES2605495T3 (en) | Atomoxetine solution | |
| JP2000159790A5 (en) | ||
| UA102254C2 (en) | Normal;heading 1;heading 2;heading 3;LIQUID FORMULATION FOR DEFERIPRONE WITH PALATABLE TASTE | |
| CY1112917T1 (en) | LIQUID ORAL COMPOSITIONS | |
| JP2018039810A5 (en) | ||
| WO2001047913A3 (en) | Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect | |
| EP1968606A4 (en) | Preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid | |
| DK1401405T3 (en) | Oral, pharmaceutical compositions with improved bioavailability | |
| AR067630A1 (en) | PHARMACEUTICAL SOLUTIONS OF TELBIVUDINE AND TREATMENT METHOD | |
| ATE457721T1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING PHARMACEUTICAL ACTIVE INGREDIENTS ABSORBED ON TITANIUM DIOXIDE DNANOPARTICLES | |
| ES2705610T3 (en) | Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population | |
| TH110374B (en) | Pharmaceutical solution | |
| TH110374A (en) | Pharmaceutical solution | |
| PL379569A1 (en) | Production method of pharmaceutical composition containing active substance ziprasidone or its pharmaceutically admitted salt, increasing solubility and bio-availability of this drug, pharmaceutical composition and application of hydrophilic auxiliary subs | |
| JP2004067516A (en) | Solution for oral use | |
| WO2010029093A3 (en) | Compositions for percutaneous administration | |
| FR2920308B1 (en) | PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ACTIVE INGREDIENTS. | |
| FR2839645B1 (en) | MULTILAMELLAR SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES (IN PARTICULAR DRUGS) BY ORAL INGESTION |